Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

KynderMed

KynderMed?uq=PEM9b6PF
2014 FOUNDED
PRIVATE STATUS
Seed LATEST DEAL TYPE
$175K LATEST DEAL AMOUNT
2 INVESTORS
Description

Developer of a medical devices designed to reduce the human tragedy and economic burden caused by preterm labor. The company's medical devices prevents premature labor, produces a drug which serves as a safe alternative to labor induction agents and can leverage new and proprietary insights into the suppression and induction of labor resulting from the regulation of melatonin.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Devices and Supplies
Other Industries
Pharmaceuticals
Primary Office
  • 954 Miccosukee Road
  • Tallahassee, FL 32308
  • United States

+1 (850) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore KynderMed’s full profile, request a free trial.

KynderMed Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 30-Nov-2015 $175K 00000 Completed Startup
2. Accelerator/Incubator 19-Jun-2015 Completed Startup
1. Angel (individual) Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

KynderMed Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Florida Institute for the Commercialization of Public Research Not-For-Profit Venture Capital Minority 000 0000 000000 0
TEC Garage Accelerator/Incubator 000 0000 000000 0

KynderMed Executive Team (3)

Name Title Board
Seat
Contact
Info
Melanie Simmons Ph.D President & Chief Executive Officer
James Olcese Ph.D Vice President & Chief Scientific Officer
Don Rosenkoetter Founder & Executive Chairman

KynderMed Board Members (1)

Name Representing Role Since Contact
Info
Don Rosenkoetter KynderMed Founder & Executive Chairman 000 0000